These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 5496789

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Rifampicin, isoniazid, ethambutol, ethionamide, and streptomycin in murine tuberculosis: comparative chemotherapeutic studies.
    Kradolfer F.
    Antibiot Chemother; 1970; 16():352-60. PubMed ID: 5523730
    [No Abstract] [Full Text] [Related]

  • 6. [Evaluation of alternative regimen of SM-INH-PAS and KM-TH-CS at three months interval in initial treatment of far advanced pulmonary tuberculosis. A report of the 12th series controlled trial of chemotherapy].
    Kekkaku; 1972 Jun; 47(6):151-8. PubMed ID: 5081204
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Results of one-year chemotherapy with isoniazid (INH), streptomycin (SM) and ethionamide (ETA) in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J, Krychniak W, Krakówka P, Buraczewska M.
    Pol Med J; 1966 Jun; 5(2):339-44. PubMed ID: 5915720
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [New combinations of drugs for the treatment of drug-resistant tuberculosis].
    Schmelev NA.
    Bull Int Union Tuberc; 1968 Dec; 41():192-3. PubMed ID: 5710248
    [No Abstract] [Full Text] [Related]

  • 12. [Evaluation of initial combined chemotherapy with SM, INH and EB for pulmonary tuberculosis. 2. Comparison of SM, EB and INH regimen with that of SM, PAS and INH for experimental tuberculosis of mice].
    Makiyama H.
    Kekkaku; 1971 Aug; 46(8):303-8. PubMed ID: 5570128
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Intermittent long-term cheomotherapy in experimental tuberculosis of the mouse].
    Grumbach F.
    Bull Int Union Tuberc; 1968 Dec; 41():303-8. PubMed ID: 5710255
    [No Abstract] [Full Text] [Related]

  • 17. Results of a trial in Morocco of intermittent treatment of pulmonary tuberculosis with combined streptomycin and isoniazid intramuscularly.
    Burzoni FJ, Durante C.
    Tubercle; 1968 Mar; 49():82-3. PubMed ID: 4872959
    [No Abstract] [Full Text] [Related]

  • 18. [Experimental studies on the effect of the combined use of 1314 Th and INH to INH-resistant tubercle bacilli from the view-point of 14C-INH uptake].
    Takae S.
    Kekkaku; 1967 Apr; 42(4):119-28. PubMed ID: 4965143
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.